Shares of Sunesis Pharmaceuticals Inc. (Nasdaq: SNSS) rallied for a third day by rising 23 cents to $1.95 after the company reported upbeat clinical trial data for its cancer treatment Voreloxin last week.
Sunesis Continues Rally
December 14, 2009 at 13:01 PM EST